Back to news 2022-05-05

Interpipe donated ca. UAH 2 mln for medical aid efforts

Interpipe, a global producer of steel pipes and railway products, systematically provides Dnipro hospitals and Ukrainian armed forces of Dnipropetrovsk region with the necessary medicines and equipment.

Interpipe together with the Foundation “Revival of the Region” which was established and financed with its support has channeled over UAH 1.8 mln for such medical aid.

With these funds, the Company purchases medicines for hospitals that receive victims from combat zone areas. Artificial blood, antiseptics, painkillers and other medications, dressings and medical supplies are provided to medical facilities. If necessary, they also provided with humanitarian efforts - hygiene products, bed linen, drinking water.

Interpipe also helps hospitals with equipment. Recently, one of the medical institutions in Dnipro was given medical furniture for the operating room: operating and manipulation tables, as well as a functional bed. An electrocoagulator was also purchased for another hospital. Last week with the support of the Victor Pinchuk Foundation the device of artificial ventilation of lungs, oxygen concentrator and ancillary equipment were donated.

Moreover, Interpipe is collecting first aid kits for mobilized workers and delivering medicines for Ukrainian defenders to the forefront.

About the company:
Interpipe is global producer of steel pipes and railway products based in Ukraine. The company’s products are marketed in more than 80 countries all around the world via the network of sales offices located in key markets of Ukraine, Europe, North America and the Middle East. In 2021, Interpipe supplied 602 kt of pipes and 174 kt of railway products.
Interpipe has 10 thousand people working at the company’s facilities. During 2021 the Company transferred ca. UAH 3bln in taxes to budgets of all levels and extra-budgetary funds.
Contacts for the mass media:
Andrey Pisarevskiy
Press Officer
Phone: +380 44 233 66 53
Cell: +380 67 952 17 62

Back to news